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Host genetic determinants that influence leukemia virus replication and expression 
play an important  role in  deciding the outcome of virus-host interactions  (1). The 
Steel locus is one locus that has been shown to influence both normal differentiation 
processes, as well as  sensitivity to the  murine leukemia virus, Friend spleen  focus- 
forming virus (SFFV). 1 Mice carrying two mutant alleles at the Steel locus (S1/SI  d) are 
severely anemic, radiosensitive, sterile, and their hair is unpigmented (2).  Although 
these  mice  are  anemic,  their  hematopoietic  tissues  contain  normal  numbers  of 
hematopoietic stem cells capable of repopulating lethally irradiated (+ /  +) hosts (3). 
In  contrast,  neither  normal  (+/+)  nor  mutant  (SI/SI  d)  hematopoietic  cells  are 
capable of curing the S1/SI  d anemia  (3, 4). Mice of genotype SI/SI  d have also been 
reported to be completely resistant to the induction of spleen foci and erythroleukemia 
by Friend  SFFV  (5).  The experiments described in  this study were undertaken  to 
determine  the  mechanism  of resistance  of SI/SI  d  mice  to  Friend  SFFV,  and  to 
determine whether SI/SI  d mice are suitable hosts for enumeration of possible tumor 
colony-forming units  (TCFU)  present  in Friend SFFV-infected  +/+  spleens.  The 
development of such  a  TCFU  assay  is  of particular  interest  because  others  have 
recently shown that spleen colony formation by Friend virus-infected spleen cells in 
secondary recipients results from virus infection of host cells, rather than proliferation 
of leukemic donor cells (6, 6a; A. A. Axelrad and H. C. Van der Gaag, University of 
Toronto, personal communication). This background of host foci arising by recruit- 
ment from infectious centers in the donor spleen can be eliminated by prior irradiation 
of the host; however, hematopoietic stem cells (CFU-S), present in the SFFV-infected 
donor  spleens  (7),  form  spleen  colonies  in  irradiated  mice  (8).  We  attempted  to 
develop a TCFU assay by using mutant SI/SI  d mice as recipients because these mice 
have been reported to be totally resistant to spleen foci induction by SFFV (5), and 
CFU-S does not form macroscopic spleen colonies in lethally irradiated S1/S1  a mice 
(3). Thus, either unirradiated or irradiated SI/SI  d secondary recipients might eliminate 
both the infectious center and CFU-S background and hence be a suitable host for an 
unambiguous TCFU assay. The results presented in this study indicate, however, that 
the spleens of normal mice infected with SFFV do not contain cells capable of colony 
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formation in Sl/S1 d hosts, although  the disease  typical of the polycythemic strain  of 
Friend SFFV can be induced in these mice. 
Materials  and Methods 
Mice.  Female mice of strain DBA/2J, aged 2-3 mo, and female F1 hybrids produced by 
crossing mice of strains WC/Re-S1/+  and C57BL/6J-+/S1  d (WCB6FI) were obtained from 
The Jackson Laboratory, Bar Harbor, Maine. This crossyields mice of four different genotypes: 
+ / +, SI/+, +/SI  d, and SI/SI  d. Mice of genotype S1/Sldhave a severe macrocytic anemia; the 
other genotypes have a normal (+ / +) or near-normal (SI/+,  +/SI  d) phenotype. 
Irradiation.  Mice were irradiated in a laTCs biological irradiator at a dose of 79.9 rads/min 
(9). 
Virus.  The virus used for infection was a NB-tropic SFFV preparation harvested from the 
medium of chronically infected NIH/3T3 cells  (10). Friend SFFV titers were determined by 
the spleen focus assay method (11) by using appropriate dilutions of the virus preparation in 
phosphate-buffered saline  (PBS).  The virus stock contained between  1 and  2  x  104 focus- 
forming units (FFLO/ml as titrated in DBA/2J mice. 
Preparation of Cell Suspensions.  Normal and SFFV-infected mouse spleen cell suspensions were 
prepared in ice-cold or-minimal  essential  medium (12) and 2% fetal calf serum (FCS) by passage 
through a stainless  steel mesh followed by gentle syringing with an 18 guage needle to break up 
remaining cell  clumps. Aliquots of the resulting suspension were taken  for cell  counting by 
using a hemocytometer. The nucleated cell concentration was then either adjusted to 1 ×  107/ 
ml in cold a-minimal essential  medium (MEM) and 2% FCS for in vitro culture or in cold PBS 
at 4  x  10  s or 1 x  107/ml  for intravenous injection into assay mice (0.5 ml/mouse). 
Preparation of Virus  from Infected Spleens.  The spleens from mice infected previously with SFFV 
were first weighed; then ice-cold ct-MEM and 2% FCS (9 ml/g spleen)  were used to make a cell 
suspension. The cells were disrupted by quickly freezing and thawing three times, followed by 
centrifugating at 8,000 g for 4 rain to remove cell debris. The virus-containing supernate was 
then passed through a 0.45/~m  Millipore filter and stored at -70°C until use. Cell-free filtrates 
were thawed quickly and diluted in cold PBS for virus titration. 
Culture of Erythroid Colonies.  The plasma clot method (13) was used with a-MEM as culture 
medium. Each plasma clot culture of 0.1 ml final vol contained 1 ×  l0  s nucleated spleen cells. 
Epo (Connaught Med. Res. Labs., Willowdale, Ontario, Canada, Step III, lot 3018) was added 
at  the onset of culture when required.  After 2 d  incubation, the clots were fixed and stained 
and colonies of eight or more cells showing a positive benzidine reaction were scored using a 
light  microscope (magnification  ×  400).  In each assay at  least  six plasma clot cultures were 
prepared for each experimental point. 
Results 
Transplantation  of SFFV-Transformed  +/+  Spleen  Cells  into  Sl/S1 d Recipients.  Fig.  1 
gives a  diagrammatic outline of the experimental  protocol. Normal WCB6F1 mice of 
+/+  genotype were  injected  intravenously  with  103  FFU  of SFFV  (as  assayed  in 
DBA/2J mice). 9 d  later,  their greatly enlarged spleens were removed and single cell 
suspensions were injected into normal  +/+  and anemic SI/SI  d recipients.  As shown 
in  Fig.  2d,  the  spleens  of the  SI/SI  d  secondary  recipients  were  greatly  enlarged, 
suggesting that SFFV-transformed cells (either donor or host) could proliferate in SI/ 
SI  d mice. 
To determine whether the cell proliferation  in these recipient  SI/SI  d mice was due 
to  growth  of  4-/+  TCFUs,  SFFV-transformed  4-/+  spleen  cells  were  also  trans- 
planted  into  SI/SI  d  recipients  that  had  been  previously  irradiated  (700  rads)  to 
prevent  infection and  transformation  of SI/SI  d host  cells  by virus released  from the 
+/+  spleen  cells.  As  shown  in  Fig.  2c,  irradiation  before  transplantation  totally 
prevented  the appearance of splenomegaly or individual  spleen colonies. During the SFFV 
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FIG.  1.  Experimental protocol  used to study the focus-forming or colony-forming ability of SFFV- 
infected  +/+  spleen cells in secondary recipients. 
FIG.  2.  Spleens of uninfected and SFFV-infected mice. a, normal SI/SI  d spleen; b, spleen from Sl/ 
Sl  d mouse  injected  9  d  previously  with  10  a FFU of SFFV;  c,  Sl/Sl  a spleen,  9  d  after whole-body 
irradiation  (700 rads) and injection of 2  ×  106 nucleated cells from the greatly enlarged spleens of 
+/+  mice injected  with SFFV 9  d  previously;  d, same as c except  d  that the SI/SI  recipients were 
not irradiated;  e, spleen from  +/+  mouse injected 9 d previously with  10  3 FFU of SFFV. 840  FRIEND ERYTHROLEUKEMIA IN MUTANT SI/SI  d MICE 
TABL~ I 
Effect of Irradiation on Focus-Forming  and Spleen Colony-Forming Capacity of 
SFFV-Infected +/+ Cells* 
Irradiation of 
Cells:[:  Recipients§ 
Recipient genotype  No. of spleen foci or spleen 
colonies 
-  -  S1/SI  d  28, TMTCII 
+  -  SI/SI  d  18, 27, 41 
-  +  SI/+  29, TMTC¶ 
+  +  S1/+  0, 0 
* See Fig.  1 for the  experimental  protocol. The number  of spleen foci or spleen 
colonies were counted 9 d after injection of the SFFV-infected + / +  cells. 
:~ Cells were irradiated with 1,200 rads. 
§ Recipient mice were irradiated with 950 rads. 
U TMTC, too many to count. 
¶ Colonies formed in the irradiated SI/+ mice  had the characteristic large appearance 
of CFU-S colonies, as opposed to the smaller size of SFFV-induced foci. 
course of three such experiments,  no spleen colonies were observed after injection of 
a  total of 5.0  x  107 SFFV-infected spleen  cells into  12  irradiated  SI/S1  d recipients. 
Thus, the SFFV-induced splenomegaly in the SI/SI  d secondary recipients appears to 
be  due  to  infection  and  proliferation  of SI/SI  d  recipient  cells,  rather  than  clonal 
growth of + /  +  TCFUs. 
To  confirm  this  conclusion,  the  donor  SFFV-infected  +/+  spleen  cells  were 
irradiated  (1,200 rads) before transplantation  into secondary recipients. If these donor 
cells were acting as infectious centers  for the release of virus in the SI/SI  d recipients, 
then a  dose of radiation sufficient to inhibit  extensive cell division should have only 
a limited effect on the appearance of spleen loci in the SI/SI  d mice. As shown in Table 
I, this  was indeed  the case. Table I  also demonstrates  that  the same irradiated  cell 
suspension which was still capable of giving rise to spleen foci in SI/S1  d mice no longer 
contained viable CFU-S, as assayed in irradiated SI/+  mice. Thus, a dose of radiation 
which prevented the cell division of CFU-S had only a marginal effect on spleen focus 
induction,  confirming that  the  secondary foci did  not  arise  by clonal expansion  of 
donor cells, but rather infection and recruitment of host S1/SI  d cells. 
Cellular  Composition of SFFV-Infected  SI/SI d Spleens.  The  spleens  of normal  mice 
infected  with  SFFV  contain  large  numbers  of cells  capable  of forming  erythroid 
colonies  in  culture  in  the  absence  of  Epo  (14,  15).  To  determine  whether  the 
splenomegaly  observed  in  SI/S1  d  mice  was  typical  of the  disease  induced  by  the 
polycythemic strain of Friend SFFV, spleen cells from S1/S1  d mice previously injected 
with SFFV-infected  +/+  cells were plated in plasma clot culture in the presence or 
absence of Epo. After 2 d  incubation,  the cultures were observed for the presence of 
hemoglobin-positive colonies.  As shown  in Table  II, the spleens  of both  uninfected 
+/+  and SI/S1  d mice contained cells that respond to Epo to form erythroid colonies. 
As expected from previous observations  (16), a  background level of apparently Epo- 
independent  colonies were observed with uninfected S1/SI  d cells, presumably due to 
carry-over of Epo from the  S1/SI  d mice,  which have been shown  to contain  a  high 
level of endogenous Epo in their  serum  (17).  Spleen  cells  from both  SFFV-infected 
+/+  mice,  and  SI/SI  d mice previously  injected  with  SFFV-infected  +/+  spleen 
cells, contained very high levels of cells capable of forming Epo-independent erythroid 
colonies in culture. Thus, by the criteria of both Epo-independence and splenomegaly, DOROTHY  McCOOL, TAK W.  MAK, AND ALAN BERNSTEIN  841 
TABLE II 
E~ythroid Colony Formation in Plasma Cultures by Spleen Cells  from Normal and SFFV-Inficted Mice 
Mouse geno-  Treatment 
type 




0  0.125  0.25 
+ / +  --  0  42~k  79 
SI/S1  a  --  30  51  95 
+/+  Infected  10 d  previously with 500  FFU of  1.1  ×  I0  n  1.1  ×  10  n  1.0 X  10~ 
SFFV 
SI/SI  a  Injected with 2  ×  10  6 SFFV-infected +/+  2.8  X  10  a  2.9  ×  I0  3.2  ×  10  2 
spleen cells 8 d previously 
SI/SI  a  Injected with 2  X  10  6 SFFV-infected +/+  2.3  X  10  a  2.1  X  10  a  2.1  ×  10  a 
spleen cells 16 d previously 
SI/SI  a  Irradiated (700 rads) and injected with 5  X  0  0  0 
106 SFFV-infected +/+  spleen  cells 8 d 
previously 
* Epo added at start of 2-d plasma clot culture. 
Numbers are mean of six determinations; standard errors of the mean of all values shown did not exceed 
10%. 
TABLE III 
Susceptibility of Normal and Mutant Mice to Spleen Foci Induction by SFFV 
Host genotype  Virus titer*  Spleen weight~ 
ffu / ml  g 
+/+  3.6  X  104  1.68 -4- 0.8 
Sl/+  3.0  X  104  0.68  :t: 0.1 
Sla/+  2.0 X  104  0.40  :t: 0.05 
SI/SI  a  4.9  X  102  0.12  +  0.01 
* A minimum of four mice/group were injected with various dilutions of a 
NB-tropic preparation of Friend SFFV. Their spleen were removed 9 d later, 
placed in Bouin's fixative, and counted for spleen foci. 
:~ Spleen weights are the average weights  =l: standard error of the mean of the 
four spleens  given  10  s  FFU of SFFV  (as  assayed  in  DBA/2J mice)  9  d 
previously. 
the disease induced in SI/SI  d mice appears to be identical to that previously described 
in  +  /  +  mice. 
Prior irradiation  of the SI/SI  a host resulted  in the total absence of cells capable of 
forming erythroid colonies  (Table  II). This observation  is consistent  with the experi- 
ment  in  Fig.  2c  showing  that  neither  donor  CFU-S  nor  TCFU  are  present  in 
irradiated  SI/SI  a recipients. 
Infection of Sl/Sl d Target Cells Directly with SFFV.  The experiments presented in Fig. 
2 suggested  that  target cells in SI/SI  d mice can be transformed  by SFFV. To confirm 
this directly, various dilutions of a  high titered preparation of SFFV  (10) were injected 
into SI/S1  d mice, and their S1/+,  Sial +, and  +  /  +  littermates. 9 d  later, their spleens 
were  removed,  placed  in  Bouin's  fixative, and  counted  for spleen  foci.  As shown  in 
Table  III  and  Fig.  2,  normal  +/+  mice  and  their  heterozygous  SI/+  and  Sld/+ 842  FRIEND  ERYTHROLEUKEMIA  IN  MUTANT  SI/SI d  MICE 
TABLE  IV 
Replication of SFFV in the Spleens of+/+ and Sl/Sl a Mice* 
Virus titer (FFU/spleen) recovered from mice of 
Experiment  genotype 
+ /  +  SI/SI a 
1  7  ×  104  8  ×  104 
2  1 X  105  4  ×  10  B 
* Spleen cells from three infected mice were pooled 9 d after infection with 5 
×  102 FFU of SFFV. Virus was prepared from the spleen cell homogenates 
as described in Materials and Methods. SFFV titers were then determined 
by the spleen focus assay method (11)  in DBA/2J  mice, by using at  least 
three mice per group. 
littermates were highly susceptible to SFFV, as assayed by spleen focus induction and 
splenomegaly, whereas anemic SI/SI  a were quite resistant  to spleen focus induction 
by SFFV. The difference between the present observation and those reported earlier 
(5) can probably be explained by the much higher titer of virus used in the present 
study. 
Replication of SFFV in Sl/Sl d Mice.  The reduced efficiency of spleen focus formation 
in SI/SI  d mice might be due to the inability of SFFV to replicate to sufficiently high 
titer in these mice. To test this possibility, the titer of SFFV recovered from the spleens 
of both  + / +  and SI/SI  a mice 9 d after injection of virus was determined. As shown 
in Table IV, SFFV grew equally well, if not somewhat better, in the spleens of SI/S1  a 
mice when compared with virus recovered from  +/+  controls. Thus, the reduced 
efficiency of spleen foci induction in anemic SI/SI  a mice does not appear to be due to 
low in vivo titers of SFFV. 
Discussion 
The results presented in this study indicate that genetically anemic SI/SI  d mice are 
50-100-fold more resistant  to spleen foci induction by SFFV, as compared to their 
normal or heterozygous littermates. This relative resistance to spleen foci and eryth- 
roleukemia induction does not appear to be due to the inability of SFFV to replicate 
in  SI/SI  a  mice.  Indeed,  the  titers  of SFFV  recovered from  SFFV-infected  SI/SI  a 
spleens were consistently somewhat  higher than  the comparable titers  from  +/+ 
mice. This observation suggests that  SFFV can replicate in vivo in cells other than 
transformed erythroid target cells, in agreement with previous observations demon- 
strating the infection and production of SFFV from nonerythroid cells in cell culture 
(10,  18,  19). 
The apparent resistance of Sl/Sl  a mice to SFFV can be overcome by the injection 
of SFFV-infected  + / +  spleen cells. The extensive splenic enlargement and appear- 
ance of large numbers of Epo-independent CFU-E in the spleens of these Sl/Sl  d mice 
appears  to result  from the  infection and  transformation of host  Sl/S1  a cells rather 
than growth of donor + / +  cells. Thus, the donor + / +  cells appear to be acting as 
infectious centers  resulting  in  high  virus  titers  in  the  Sl/Sl  d spleens.  These results 
suggest that, at sufficiently high virus titers, the extrinsic factors in the Steel environ- 
ment which limit the proliferation of virally-transformed cells can be overcome. The 
observation  that  SFFV  can  infect  and  transform  cells  in  Sl/Sl  a  mice,  albeit  at  a 
reduced  frequency, makes  it  less  likely that  the  proliferation of TCFU  would  be DOROTHY McCOOL, TAK W.  MAK, AND ALAN BERNSTEIN  843 
completely blocked in these mice. In addition, previous work has shown that normal 
hematopoietic progenitor cells, including CFU-S and CFU-C, were capable of exten- 
sive proliferation in irradiated S1/SI  d mice (20). The observation that normal hema- 
topoietic cells can proliferate in irradiated S1/SI  d mice makes it unlikely that TCFU, 
if they existed, would be totally inhibited from forming spleen colonies in these same 
mice. Together, these results suggest that, in its initial phase, the disease induced by 
the polycythemic strain of Friend SFFV is not the result of the clonal proliferation of 
transformed erythroid progenitor cells; rather, it would appear that the large increase 
in  cell proliferation in  the  spleens of SFFV-infected mice  results  from continuous 
infection and  recruitment of normal erythroid cells with  only limited  proliferative 
capacity. This conclusion is consistent with a previous observation from this labora- 
tory, based on the multihit kinetics of titration of a Friend virus stock which contains 
SFFV in excess to its helper virus, that primary spleen foci also arise by a process of 
continuous infection and recruitment of newly transformed cells, rather than by clonal 
growth from a single transformed cell (10). 
The conclusion that  the leukemic spleens of SFFV-infected mice do not contain 
TCFU is seemingly at odds with the observation that  permanent cell lines can  be 
established in cell culture from these spleens. These apparently contradictory findings 
can be reconciled as follows:  (a) TCFU may only start to appear in SFFV-infected 
spleens at much later times then examined in this study. Because the disease regresses 
in the  + /  +  mice used in this study, we were unable to look for TCFU at later times. 
(b) Cells capable of forming permanent lines in cell culture (and also forming spleen 
colonies  in  irradiated  recipients)  may not  pre-exist  in  these  leukemic  spleens,  but 
rather may only arise in cell culture. While no direct evidence exists to support this 
hypothesis, it is relevant to note that these Friend cell lines do not emerge immediately 
after placing  leukemic spleen cells in  culture;  rather,  a  dormant  period of several 
weeks in culture, or subcutaneous passage in vivo (21, 22), appears to be first necessary 
before cells capable of rapid and extensive proliferation emerge in the culture dish. 
The predominant class of cells which are transformed by SFFV appear to be the 
same as that which normally respond to Epo by proliferating and differentiating into 
mature  erythroid cells  (23,  24).  These  SFFV-transformed  cells  appear  to  become 
independent of the positive regulatory controls that Epo normally exerts on erythroid 
progenitor cells (25,  26). Genetically anemic SI/SI  d mice are unresponsive in vivo to 
the stimulatory effects of Epo on erythropoiesis (17, 27), even though the in vivo levels 
of Epo are very high in SI/SI  d mice (16,  17). It is of interest to note, therefore, that 
although the susceptible populations for both Epo and SFFV appear to be identical 
or very similar, and  although the effects of Epo and  SFFV resemble each other in 
many  ways,  cells  in  S1/SI  d mice  cannot  effectively respond  to  high  levels of Epo 
whereas high doses of SFFV are still effective in promoting erythroid differentiation 
in SI/SI  d mice. 
The regulation oferythroid progenitor cells by Epo, both in vivo and in cell culture, 
has been widely accepted as a normal feature of erythropoiesis. Conversely, the Epo- 
independent proliferation of erythroid cells in vivo and  in cell culture, observed in 
both  Friend  disease  and  the  human  disease polycythemia vera  (28,  29),  has  been 
associated with abnormal leukemic regulation. Recent observations by Johnson and 
Metcalf  (30),  however,  suggest  that  normal  cells  from  mouse  fetal  liver  are  also 
capable of  extensive erythroid differentiation in the absence of  Epo. These observations 
suggest that Friend SFFV, rather than initiating a new program of leukemic erythroid 844  FRIEND ERYTHROLEUKEMIA IN MUTANT SI/SI  d MICE 
differentiation, may be activating or amplifying normal regulatory events which are 
Epo-independent.  This  conclusion  is  consistent  with  observations  to  be  published 
elsewhere from this laboratory that normal hematopoietic cells express cellular RNA 
sequences which are related to possible transforming sequences on the SFFV genome. 
It  also  would  explain  why,  at  least  in  the  initial  phase  of Friend  disease,  SFFV- 
transformed cells, like their normal counterparts, are still subject  to the regulatory 
influences of the Steel locus. 
Summary 
Genetically anemic  SI/SI  d mice have been shown  previously to have a  defective 
hematopoietic  environment  which  prevents  extensive  erythroid  differentiation  of 
normal hematopoietic stem cells and also confers resistance to the erythroleukemia- 
inducing virus, Friend spleen focus-forming virus (SFFV). In this study, we show that 
the relative resistance of S1/SI  a mice to transformation by SFFV is not  due to the 
inability of SFFV to replicate, nor is  it because SFFV cannot transform erythroid 
cells, in  the spleens of these mice. Injection of syngeneic  +/+  mouse spleen cells, 
previously infected in vivo with  SFFV, into secondary S1/SI  d recipients resulted in 
marked splenic enlargement, and the appearance of large numbers of erythropoietin 
(Epo)-independent erythroid colonies in plasma clot culture. The cellular proliferation 
observed in  these  SI/SI  d secondary recipients appeared  to be due to infection and 
transformation of host SI/SI  d cells rather than the growth of possible tumor colony- 
forming units  (TCFU) present in the infected  +/+  spleens, because preirradiation 
of the SI/S1  d recipients abolished the splenomegaly and appearance of Epo-independ- 
ent  erythroid colonies. Furthermore, prior irradiation  (1,200 rads)  of donor spleen 
cells from SFFV-infected +/+  mice only slightly reduced spleen focus formation in 
unirradiated SI/SI  d recipients. The conclusion that SI/SI  d target cells could be infected 
and transformed by SFFV was confirmed directly by injecting a high titered prepa- 
ration of SFFV into S1/SI  d mice. SI/S1  a mice were not absolutely resistant to infection 
or transformation  by SFFV.  Nevertheless, cells  from the spleens of SFFVdnfected 
mice were  unable  to  form tumor  colonies  (TCFU)  in  irradiated  S1/SI  d recipients, 
suggesting that TCFU are either present at an undetectably low frequency in these 
spleens, or that they are still subject to the regulatory influences of the Steel locus. 
The authors acknowledge helpful discussions with Dr. E. A. McCulloch during the preparation 
of this manuscript. Mr. George Cheong l~rovided excellent technical assistance. 
Received  for publication 4 December 1978. 
References 
1.  Lilly, F., and T. Pincus.  1973. Genetic control of murine viral leukemogenesis. Adv. Cancer 
Res. 17:231. 
2.  Russell, E. S. 1970. Abnormalities  of erythropoiesis associated with mutant genes in mice. 
In Regulation of Hematopoiesis. A. S, Gordon, editor. Appleton-Century Crofts, New York. 
649. 
3.  McCulloch, E. A., L. Siminovitch, J. E. Till, E. S. Russell, and S. E. Bernstein.  1965. The 
cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype 
SI/SI d. Blood. 26:399. 
4.  Bernstein,  S.  E.  1970. Tissue  transplantation  as  an  analytic  and  therapeutic  tool  in 
hereditary anemias. Am. J. Surg. 119:448. DOROTHY McCOOL, TAK W.  MAK, AND ALAN BERNSTEIN  845 
5.  Bennett, M., R. A. Steeves, G. Cudkowicz, E. A. Mirand, and L. B. Russell.  1968. Mutant 
Sl alleles  of mice affect susceptibility to Friend spleen focus-forming virus. Science  (Wash. 
D. C.). 162:564. 
6.  Steeves,  R.  A., J.  E.  Bubbers,  F.  Plata,  and  F.  Lilly.  1978. Origin  of spleen  colonies 
generated by Friend virus-infected cells in mice. Cancer Res. 38:2729. 
6a.Wendling,  F.,  and  P.  E.  Tambourin.  1978. Oncogenicity of Friend-virus-infected  cells: 
determination of origin of spleen colonies by the H-2 antigens as genetic markers. Int. J. 
Cancer. 22:479. 
7.  Thomson, S., and A. A. Axelrad.  1968. A quantitative spleen colony assay for tumor cells 
induced by Friend leukemia virus infection in mice. Cancer Res.  28:2105. 
8.  Till, J. E., and E. A. McCulloch. 1961. A direct measurement of the radiation sensitivity of 
normal mouse bone marrow cells. Radiat.  Res.  14.'213. 
9.  Cunningham, J.  R., W.  R.  Bruce,  and  H.  P,  Wehb.  1965. A  convenient  laTCs unit  for 
irradiating cell suspensions and small laboratory animals. Phys.  Med.  Biol.  10,381. 
10.  Bernstein, A., T. W. Mak, and J. R. Stephenson.  1977. The Friend virus genome: evidence 
for the stable association of MuLV sequences and sequences involved in erythroleukemie 
transformation. Cell.  12:287. 
1 I.  Axelrad, A. A., and R. A. Steeves.  1964. Assay for Friend leukemia virus: rapid quantitative 
method based on enumeration of macroscopic spleen loci in mice.  Virology. 24:513. 
12.  Stanners,  C.  P.,  G.  L. Eliceiri,  and  H. Green.  1971. Two types of ribosomes in mouse- 
hamster hybrid cells. Nature (Lond.).  230,52. 
13.  McLeod, D. L., M. M. Shreeve, and A. A. Axelrad. 1974. Improved plasma culture system 
for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E. Blood. 
44:517. 
14.  Liao, S.-K., and A. A. Axeirad.  1975. Erythropoietin-independent erythoid colony forma- 
tion in vitro by hemopoietic cells of mice infected with Friend virus. Int. J.  Cancer. 15:467. 
15.  Horoszewicz, J. S., S. S. Leong, and W. A. Carter.  1975. Friend leukemia: rapid develop- 
ment of erythropoietin-independent  hematopoietic precursors. J.  Natl.  Cancer Inst. 54:265. 
16.  Chui,  D.  H.  K., and  B.  V.  Loyer.  1975. Erythropoiesis in Steel mutant  mice: effects  of 
erythropoietin in vitro. Blood. 45:427. 
17.  Bernstein, S. E., E. S. Russell, and G. Keighley. 1968. Two hereditary mouse anemias (SI/ 
SI  J and W/W*) deficient in response to erythropoietin, Ann. N.  Y. Acad.  Sci.  149.475. 
18.  Eekner, R. J.  1975. Continuous replication of Friend virus complex (spleen  focus-forming 
virus-lymphatic leukemia-inducing virus)  in mouse embryo fibroblasts.  Retention of leu- 
kemogenicity and loss of immunosuppressive properties. J. Exp. Med.  142:936. 
19.  Clarke,  B. J., A. A. Axelrad, and D.  Housman.  1976. Friend spleen focus-forming virus 
production in vitro by a non-erythroid cell line. J. Natl.  Cancer Inst. 57:853. 
20.  Sutherland, D. J. A., J. E. Till, and E. A. McCulloch.  1970. A kinetic study of the genetic 
control of hemopoietic progenitor cells assayed in euhure and in vivo. J. Cell. Physiol.  75:267. 
21.  Friend, C., and J. R. Haddad.  1960. Tumor formation with transplants of spleen and liver 
from mice with virus-induced leukemia.J.  Natl.  Cancer Inst. 25:1279. 
22.  Freedman, H. A., and F. Lilly.  1975. Properties of cell lines derived from tumors induced 
by Friend virus in BALB/e and BALB/c-H-2  b mice. J. Exp. Med.  142:212. 
23.  Steeves,  R. A., E. A. Mirand, S. Thomas, and L. Avila. 1969. Enhancement of spleen focus 
formation and virus replication in Friend virus infected mice.  Cancer Res. 29.1111. 
24.  Tambourin, P., and F.  Wendling.  1974. Malignant  transformation and erythroid differ- 
entiation by polyeythaemia-indueing Friend virus.  Nat. New Biol. 234:230. 
25.  Mirand,  E.  A.,  R.  A.  Steeves,  R.  D.  Lange,  and J.  T.  Grace Jr.  1968. Virus-induced 
polycythemia in mice: erythropoiesis without erythropoietin. Proc. Soc. Exp.  Biol.  Med.  128: 
844. 
26.  Sassa,  S.,  F.  Takaku,  and  K.  Nakao.  1968. Regulation  of erythropoiesis  in  the  Friend 
leukemia mouse. Blood. 31:758. 846  FRIEND  ERYTHROLEUKEMIA  IN  MUTANT SI/SI  d MICE 
27.  Harrison, D. E., and E. S. Russell.  1972. The response ofW/W  v and SI/S1  d anemic mice to 
haemopoietic stimuli. Br. J. Haematol.  22:155. 
28.  Adamson, J. W.  1968. The erythropoietin/hematocrit relationship in normal and polycy- 
themic man: implications of marrow regulation. Blood. 32:597. 
29.  Prchal, J. F., and A. A. Axelrad. 1974. Bone-marrow responses  in polycythemia  vera. N.. Engl. 
J. Med.  290:1382. 
30. Johnson, G. R., and D. Metcalf. 1977. Pure and mixed erythroid colony formation m vitro 
stimulated by spleen conditioned medium with no detectable erythropoietin. Proc. Natl. 
Acad.  Sci.  U. S. A. 74:3879. 